Suppr超能文献

多次口服给药后苯巴比妥在猫体内的药代动力学

Pharmacokinetics of phenobarbital in the cat following multiple oral administration.

作者信息

Cochrane S M, Parent J M, Black W D, Allen D G, Lumsden J H

机构信息

Department of Clinical Studies, Ontario Veterinary College, University of Guelph.

出版信息

Can J Vet Res. 1990 Jun;54(3):309-12.

Abstract

Phenobarbital was administered orally to seven healthy cats at a dose of 5 mg/kg once a day for 21 days. Serum phenobarbital concentrations were determined using a commercial immunoassay technique. A one-compartment model was used to describe the final elimination curve. The elimination half-life (t1/2 b) after the final day of treatment was 43.3 +/- 2.92 h. The large apparent volume of distribution of 695.0 +/- 43.9 mL/kg suggests that the drug was widely distributed within the body. The t1/2 b following multiple oral administration was significantly shorter than previously reported for a single oral dose of phenobarbital in the cat. Analysis of pharmacokinetic results after days 1 and 21 of treatment suggested that the elimination kinetics of phenobarbital did not change significantly with multiple oral administration. It appears that differences in elimination kinetics can exist between populations of cats. These differences emphasize the need for individual monitoring of cats receiving phenobarbital.

摘要

对7只健康猫口服苯巴比妥,剂量为5毫克/千克,每日一次,持续21天。使用商业免疫测定技术测定血清苯巴比妥浓度。采用一室模型描述最终消除曲线。治疗最后一天后的消除半衰期(t1/2 b)为43.3±2.92小时。695.0±43.9毫升/千克的较大表观分布容积表明该药物在体内广泛分布。多次口服给药后的t1/2 b明显短于先前报道的猫单次口服苯巴比妥的情况。治疗第1天和第21天后的药代动力学结果分析表明,多次口服给药后苯巴比妥的消除动力学没有显著变化。似乎不同猫群之间的消除动力学可能存在差异。这些差异强调了对接受苯巴比妥治疗的猫进行个体监测的必要性。

相似文献

6
Pharmacokinetics and suggested oral dosing regimen of cisapride: a study in healthy cats.
J Am Anim Hosp Assoc. 1997 Nov-Dec;33(6):517-23. doi: 10.5326/15473317-33-6-517.
7
Pharmacokinetics of oral pimobendan in healthy cats.
J Vet Cardiol. 2012 Dec;14(4):489-96. doi: 10.1016/j.jvc.2012.06.002. Epub 2012 Oct 30.
8
Evaluation of Transdermal Administration of Phenobarbital in Healthy Cats.
J Am Anim Hosp Assoc. 2019 Jan/Feb;55(1):1-7. doi: 10.5326/JAAHA-MS-6670. Epub 2018 Nov 14.
9
Pharmacokinetics and safety of penciclovir following oral administration of famciclovir to cats.
Am J Vet Res. 2007 Nov;68(11):1252-8. doi: 10.2460/ajvr.68.11.1252.
10
Pharmacokinetics of intravenous and oral methimazole following single- and multiple-dose administration in normal cats.
J Vet Pharmacol Ther. 1991 Dec;14(4):367-73. doi: 10.1111/j.1365-2885.1991.tb00850.x.

引用本文的文献

1
Once-a-day oral treatment with phenobarbital in cats with presumptive idiopathic epilepsy.
J Feline Med Surg. 2023 Sep;25(9):1098612X231196806. doi: 10.1177/1098612X231196806.
2
Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan.
Open Vet J. 2023 Jul;13(7):846-853. doi: 10.5455/OVJ.2023.v13.i7.6. Epub 2023 Jul 31.
4
Seizures and epilepsy in cats.
Vet Med (Auckl). 2014 Jul 30;5:41-47. doi: 10.2147/VMRR.S62077. eCollection 2014.
5
Prevalence and clinical characteristics of phenobarbitone-associated adverse effects in epileptic cats.
J Feline Med Surg. 2021 Feb;23(2):59-66. doi: 10.1177/1098612X20924925. Epub 2020 Jun 2.
6
Interaction of cyclosporine with phenobarbital in cats: a preliminary study.
J Vet Med Sci. 2019 Nov 29;81(11):1621-1623. doi: 10.1292/jvms.19-0339. Epub 2019 Oct 8.
7
Prospective crossover clinical trial comparing transdermal with oral phenobarbital administration in epileptic cats.
J Feline Med Surg. 2019 Dec;21(12):1181-1187. doi: 10.1177/1098612X18823577. Epub 2019 Jan 28.
8
Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats.
J Vet Intern Med. 2019 Mar;33(2):827-830. doi: 10.1111/jvim.15412. Epub 2019 Jan 21.
9
Recurrent seizures in cats: Treatment - which antiepileptic drugs are recommended?
J Feline Med Surg. 2018 Sep;20(9):825-834. doi: 10.1177/1098612X18791874.
10
Systematic review of antiepileptic drugs' safety and effectiveness in feline epilepsy.
BMC Vet Res. 2018 Mar 2;14(1):64. doi: 10.1186/s12917-018-1386-3.

本文引用的文献

2
Kinetics of phenobarbital in normal subjects and epileptic patients.
Eur J Clin Pharmacol. 1982;23(1):87-92. doi: 10.1007/BF01061382.
4
Preliminary study on the pharmacokinetics of phenobarbital in the neonatal foal.
Equine Vet J. 1984 Jul;16(4):368-71. doi: 10.1111/j.2042-3306.1984.tb01946.x.
5
Blood levels of drug at the equilibrium state after multiple dosing.
Nature. 1965 Sep 18;207(5003):1301-2. doi: 10.1038/2071301a0.
6
Study on combined treatment with phenobarbital and diphenylhydantoin.
Acta Pharmacol Toxicol (Copenh). 1968;26(3):284-92. doi: 10.1111/j.1600-0773.1968.tb00447.x.
7
Disappearance of phenobarbital and diphenylhydantoin from serum of children.
Clin Pharmacol Ther. 1970 Sep-Oct;11(5):674-9. doi: 10.1002/cpt1970115674.
8
Metabolic interactions among environmental chemicals and drugs.
Science. 1972 Nov 10;178(4061):576-86. doi: 10.1126/science.178.4061.576.
10
Absorption kinetics and bioavailability of phenobarbital after oral administration to dogs.
J Vet Pharmacol Ther. 1985 Jun;8(2):205-7. doi: 10.1111/j.1365-2885.1985.tb00946.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验